Cargando…

Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room Settings: A Meta-analysis

IMPORTANCE: Compared with the operating room (OR), office-based intravitreal injection (IVI) is considered a more cost-effective and convenient approach, yet clinical outcomes of IVIs with anti–vascular endothelial growth factor (VEGF) agents in different settings (office-based vs OR) have not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tong, Sun, Junran, Min, Jingyu, Zhou, Shuangwen, Zhu, Xiaolin, Jia, Huixun, Sun, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377608/ https://www.ncbi.nlm.nih.gov/pubmed/34410325 http://dx.doi.org/10.1001/jamaophthalmol.2021.3096

Ejemplares similares

Incidence of Endophthalmitis after Intravitreal Anti-Vascular Endothelial Growth Factor Injections in an Operating Room in China
por: Chen, Yanyun, et al.
Publicado: (2020)

Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan
por: Hashimoto, Yohei, et al.
Publicado: (2022)

The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey
por: Veritti, Daniele, et al.
Publicado: (2023)

Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
por: Sindal, Manavi D, et al.
Publicado: (2021)

Safety of simultaneous bilateral intravitreal versus unilateral anti-vasculo-endothelial growth factors injection in an operating room setting
por: Jeeva, Irfan Kabiruddin, et al.
Publicado: (2022)

Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach
por: Petri, Anne-Sofie, et al.
Publicado: (2020)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

A Comparison of Conventional Intravitreal Injection Method vs InVitria Intravitreal Injection Method
por: Blyth, Michelle, et al.
Publicado: (2020)

Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
por: Wang, Donghyun, et al.
Publicado: (2014)

Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy
por: Kianersi, Farzan, et al.
Publicado: (2021)

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
por: Rai, Bhim Bahadur, et al.
Publicado: (2023)

Subtenon Vs Intravitreal Triamcinolone injection in Diabetic Macular Edema, A prospective study in Chinese population
por: Luo, Dawei, et al.
Publicado: (2014)

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline
por: Nikkhah, Homayoun, et al.
Publicado: (2018)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão, Miguel, et al.
Publicado: (2017)

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
por: Labardini, Cecilia P., et al.
Publicado: (2018)

Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection
por: Kaya, Mahmut, et al.
Publicado: (2021)

Intravitreal anti-vascular endothelial growth factor injections to treat post-trabeculectomy Swan syndrome
por: Feu-Basilio, Silvia, et al.
Publicado: (2022)

Baseline characteristics and progression of neovascular age-related macular degeneration in patients receiving over 60 intravitreal injections of anti-vascular endothelial growth factor
por: Prahs, Philipp, et al.
Publicado: (2023)

Development of Collapsing Focal and Segmental Glomerulosclerosis After Receiving Intravitreal Vascular Endothelial Growth Factor Blockade
por: Nobakht, Niloofar, et al.
Publicado: (2019)

Office-based vs. operating room-performed laryngopharyngeal surgery: a review of cost differences
por: Schimberg, Anouk S., et al.
Publicado: (2019)

Vascular endothelial growth factor-A level in human breast milk after intravitreal injection of ranibizumab: a case report
por: Huang, Ying, et al.
Publicado: (2022)

State and Trait Anxiety Scores of Patients Receiving Intravitreal Injections
por: Kayikcioglu, Ozcan, et al.
Publicado: (2017)

Factors Associated with Pain Level in Patients Receiving Intravitreal Injection
por: İnaltekin, Ali, et al.
Publicado: (2021)

Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
por: Chang, Margaret A., et al.
Publicado: (2022)

Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study
por: Campbell, Robert J, et al.
Publicado: (2012)

Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas
por: Lee, Jung Pil, et al.
Publicado: (2016)

Pituitary Apoplexy After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitor: A Novel Complication
por: Kasl, Rebecca A., et al.
Publicado: (2015)

Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review
por: Merani, Rohan, et al.
Publicado: (2015)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
por: Chen, Xuting, et al.
Publicado: (2019)

Nephrotic Syndrome with Focal Segmental Glomerulosclerosis Induced by Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitor
por: Kakeshita, Kota, et al.
Publicado: (2020)

Nutritionally variant streptococci causing endophthalmitis associated with intravitreal anti-vascular endothelial growth factor injection
por: Steinmetz, Robert L., et al.
Publicado: (2021)

The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2023)

Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents
por: Kiddee, Weerawat, et al.
Publicado: (2015)

Long-Term Resolution of Perifoveal Exudative Vascular Anomalous Complex after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor
por: Torrell-Belzach, Nuria, et al.
Publicado: (2022)

Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension
por: Hanna, Ramy M, et al.
Publicado: (2018)

The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti–Vascular Endothelial Growth Factor Injections
por: Patel, Samir N., et al.
Publicado: (2021)

Hemodynamic and structural changes in retinal arterial macroaneurysm after intravitreal anti-vascular endothelial growth factor injection
por: Kadomoto, Shin, et al.
Publicado: (2021)

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
por: Taher, Nada O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1t25qo3toikrlnubfvu92inqou